AMY JONES: Open Payments
NPI 1851771729 · ASHLAND, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 24 payments from 9 companies in 2025. Trend: 2023 $482 · 2024 $667 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $180 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| Novo Nordisk Inc | 3 | $53 |
| Dexcom, Inc. | 1 | $33 |
| Exact Sciences Corporation | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Amgen Inc. | 1 | $14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: VRAYLAR, UBRELVY, QULIPTA, Kerendia, Ozempic, Dexcom G6 Transmitter, Cologuard Collection Kit, BREZTRI.
Industry payments across AL — which companies pay providers there.
